Nitrosative stress with HIV dementia causes decreased L-prostaglandin D synthase activity
暂无分享,去创建一个
J. McArthur | N. Sacktor | A. Nath | R. Cotter | R. Gundry | W. Li | T. Malpica-Llanos
[1] A. Nath,et al. Neurologic complications: Challenges to the diagnosis and management of HIV dementia , 2006 .
[2] Caroline Anderson,et al. Oxidative stress and therapeutic approaches in HIV dementia. , 2006, Antioxidants & redox signaling.
[3] M. Mattson,et al. Increased vulnerability of ApoE4 neurons to HIV proteins and opiates: Protection by diosgenin and l-deprenyl , 2006, Neurobiology of Disease.
[4] I. Singh,et al. Pharmacological strategies for the regulation of inducible nitric oxide synthase: Neurodegenerative versus neuroprotective mechanisms , 2006, Neurochemistry International.
[5] A. Nath,et al. Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures: the role of oxidative stress and D1 dopamine receptor. , 2006, Neurotoxicology.
[6] A. Nath,et al. Estrogen attenuates gp120‐ and tat1–72‐induced oxidative stress and prevents loss of dopamine transporter function , 2006, Synapse.
[7] Linda Chang,et al. Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities. , 2005, The American journal of psychiatry.
[8] T. Hand,et al. Prostaglandin D2 mediates neuronal protection via the DP1 receptor , 2005, Journal of neurochemistry.
[9] M. Hersberger,et al. CCTTT‐repeat polymorphism of the inducible nitric oxide synthase is not associated with HIV pathogenesis , 2004, Clinical and experimental immunology.
[10] D. Price,et al. Stabilization of α-Synuclein Protein with Aging and Familial Parkinson's Disease-Linked A53T Mutation , 2004, The Journal of Neuroscience.
[11] P. Singhal,et al. Morphine modulates HIV-1 gp160-induced murine macrophage and human monocyte apoptosis by disparate ways , 2004, Journal of Neuroimmunology.
[12] M. Mattson,et al. Perturbation of sphingolipid metabolism and ceramide production in HIV‐dementia , 2004, Annals of neurology.
[13] R. Aebersold,et al. A statistical model for identifying proteins by tandem mass spectrometry. , 2003, Analytical chemistry.
[14] S. Fujimoto,et al. Subject Index Vol. 59, 2003 , 2003, Hormone Research in Paediatrics.
[15] R. Kuljiš,et al. Increased density of neurons containing NADPH diaphorase and nitric oxide synthase in the cerebral cortex of patients with HIV-1 infection and drug abuse. , 2003, Journal of neuro-AIDS.
[16] D. Butterfield,et al. Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants , 2003, Neurology.
[17] K. Pahan,et al. Human Immunodeficiency Virus Type 1 (HIV-1) Tat Induces Nitric-oxide Synthase in Human Astroglia* , 2002, The Journal of Biological Chemistry.
[18] Alexey I Nesvizhskii,et al. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. , 2002, Analytical chemistry.
[19] Y. Urade,et al. Perineuronal Oligodendrocytes Protect against Neuronal Apoptosis through the Production of Lipocalin-Type Prostaglandin D Synthase in a Genetic Demyelinating Model , 2002, The Journal of Neuroscience.
[20] M. Fresno,et al. Tumor necrosis factor-alpha and nitric oxide in vertically HIV-1-infected children: implications for pathogenesis. , 2001, European cytokine network.
[21] W. Slikker,et al. Methamphetamine‐Induced Dopaminergic Neurotoxicity: Role of Peroxynitrite and Neuroprotective Role of Antioxidants and Peroxynitrite Decomposition Catalysts , 2001, Annals of the New York Academy of Sciences.
[22] A. Bansal,et al. Oxidative damage induced by the injection of HIV-1 Tat protein in the rat striatum , 2001, Neuroscience Letters.
[23] Sunhee C. Lee,et al. Expression of inducible nitric oxide synthase, interleukin-1 and caspase-1 in HIV-1 encephalitis , 2001, Journal of Neuroimmunology.
[24] M. Mattson,et al. Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine , 2001, BMC Neuroscience.
[25] J. Trojanowski,et al. Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies. , 2000, The American journal of pathology.
[26] Y. Urade,et al. Biochemical, structural, genetic, physiological, and pathophysiological features of lipocalin-type prostaglandin D synthase. , 2000, Biochimica et biophysica acta.
[27] D. Dormont,et al. Nitric Oxide Synthesis Enhances Human Immunodeficiency Virus Replication in Primary Human Macrophages , 2000, Journal of Virology.
[28] Syed F. Ali,et al. Comparison between the Role of the Neuronal and Inducible Nitric Oxide Synthase in Methamphetamine‐induced Neurotoxicity and Sensitization , 2000, Annals of the New York Academy of Sciences.
[29] S. Senok,et al. Methamphetamine‐induced Oxidative Stress in Cultured Mouse Astrocytes , 2000, Annals of the New York Academy of Sciences.
[30] G. Levi,et al. Human immunodeficiency virus type 1 Tat protein stimulates inducible nitric oxide synthase expression and nitric oxide production in microglial cultures. , 1999, Journal of neuropathology and experimental neurology.
[31] T. Kemper,et al. Human immunodeficiency virus infection, inducible nitric oxide synthase expression, and microglial activation: Pathogenetic relationship to the acquired immunodeficiency syndrome dementia complex , 1999, Annals of neurology.
[32] H. Toh,et al. Binding of biliverdin, bilirubin, and thyroid hormones to lipocalin-type prostaglandin D synthase. , 1999, Biochemistry.
[33] E. Murray,et al. Increased expression of nitric oxide synthase and dendritic injury in simian immunodeficiency virus encephalitis. , 1999, Journal of human virology.
[34] S. Lipton,et al. The contribution of various NOS gene products to HIV-1 coat protein (gp120)-mediated retinal ganglion cell injury. , 1999, Investigative ophthalmology & visual science.
[35] D. Troost,et al. Nitric oxide synthase expression and apoptotic cell death in brains of AIDS and AIDS dementia patients. , 1999, AIDS.
[36] J. McArthur,et al. Rate and Severity of HIV-Associated Dementia (HAD): Correlations with Gp41 and iNOS , 1999, Molecular medicine.
[37] Y. Urade,et al. Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[38] Y. Urade,et al. Prostaglandin D2 and sleep regulation. , 1999, Biochimica et biophysica acta.
[39] T. Dawson,et al. Mechanisms and Structural Determinants of HIV-1 Coat Protein, gp41-Induced Neurotoxicity , 1999, The Journal of Neuroscience.
[40] M. Mattson,et al. HIV-1 Protein Tat Induces Apoptosis of Hippocampal Neurons by a Mechanism Involving Caspase Activation, Calcium Overload, and Oxidative Stress , 1998, Experimental Neurology.
[41] P. Simmonds,et al. HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement. , 1998, Brain : a journal of neurology.
[42] B. Yamamoto,et al. The effects of methamphetamine on the production of free radicals and oxidative stress. , 1998, The Journal of pharmacology and experimental therapeutics.
[43] C P Das,et al. Neurological complications of HIV infection. , 1998, Neurology India.
[44] W. Sheng,et al. Immunomodulatory role of opioids in the central nervous system. , 1998, Archivum immunologiae et therapiae experimentalis.
[45] P. Lantos,et al. HIV‐associated brain pathology in the United Kingdom: an epidemiological study , 1997, AIDS.
[46] Y. Urade,et al. Lipocalin-type Prostaglandin D Synthase (β-Trace) Is a Newly Recognized Type of Retinoid Transporter* , 1997, The Journal of Biological Chemistry.
[47] Justin C. McArthur,et al. Immunologic NO Synthase: Elevation in Severe AIDS Dementia and Induction by HIV-1 gp41 , 1996, Science.
[48] J. Egberts,et al. Urine samples before dinner are preferable when studying changes in endogenous nitrate production under uncontrolled dietary conditions. , 1996, Clinica chimica acta; international journal of clinical chemistry.
[49] T. Clark,et al. Investigation of the Uncatalyzed Hydration of CO2 and First Approximations to the Active Site of Carbonic Anhydrase - A Combined Ab initio and DFT Study - , 1996 .
[50] G. Nuovo,et al. AIDS Dementia Is Associated with Massive, Activated HIV-1 Infection and Concomitant Expression of Several Cytokines , 1996, Molecular medicine.
[51] S. Wesselingh,et al. Elevated central nervous system prostaglandins in human immunodeficiency virus—associated dementia , 1994, Annals of neurology.
[52] U. Testa,et al. gp120 HIV envelope glycoprotein increases the production of nitric oxide in human monocyte‐derived macrophages , 1994, Journal of leukocyte biology.
[53] J. R. Lancaster,et al. Nitric oxide--a new endogenous immunomodulator. , 1993, Transplantation.
[54] D. Vlahov,et al. HIV‐1 infection and nervous system abnormalities among a cohort of intravenous drug users , 1991, Neurology.
[55] M. Ebadi,et al. Reactive Macrophages Increase Oxidative Stress and Alpha-Synuclein Nitration During Death of Dopaminergic Neuronal Cells in Co-Culture: Relevance to Parkinson’s Disease , 2005, Neurochemical Research.
[56] Richard Graham Knowles,et al. Inducible nitric oxide synthase is involved in the mechanisms of cocaine enhanced neuronal apoptosis induced by HIV-1 gp120 in the neocortex of rat. , 2004, Neuroscience letters.
[57] K. Kiyomiya,et al. Involvement of arachidonic acid metabolites in acute inflammation: detection of 6-keto-PGF1 alpha, thromboxane B2 and PGD2 in rat pleurisy induced by phorbol myristate acetate. , 1985, Japanese journal of pharmacology.